SCHEMBL9707725

SCHEMBL9707725

Cc1nc2c(c(=O)[nH]c(=O)n2C(C)c2ccccc2)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
KDM4E B2RXH2 4/20 0.40
HTT P42858 3/20 0.40
HPGD P15428 2/20 0.40
MAPT P10636 2/20 0.40
GAA P10253 1/20 0.40
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
CXCL8 P10145 1/20 0.39
NOD2 Q9HC29 1/20 0.39
NOD1 Q9Y239 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
POLB P06746 2/20 0.37
PKM P14618 1/20 0.37
MCL1 Q07820 1/20 0.37
AGTR1 P30556 1/20 0.37
AGTR2 P50052 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9708293 0.91 USP1 (0.39) ALDH1A1KDM4EHTTHPGDMAPT
SCHEMBL9708377 0.90 AGTR1 (0.43) ALDH1A1KDM4EMEN1KMT2ACXCL8
SCHEMBL9708926 0.89 AGTR1 (0.44) MEN1KMT2AAGTR1AGTR2
SCHEMBL9707480 0.89 KDM4E (0.42) ALDH1A1KDM4EHTTHPGDMAPT
SCHEMBL9708834 0.88 MEN1 (0.39) ALDH1A1KDM4EHTTHPGDMAPT
SCHEMBL9708267 0.88 AGTR1 (0.47) AGTR1AGTR2
SCHEMBL9708201 0.87 AGTR1 (0.44) AGTR1AGTR2
SCHEMBL9707618 0.87 AGTR1 (0.37) AGTR1AGTR2
SCHEMBL9708436 0.86 KMT2A (0.48) ALDH1A1KDM4EHTTHPGDMAPT
SCHEMBL9708831 0.86 HPGD (0.39) ALDH1A1HTTHPGDMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed